TABLE OF CONTENTS
1 INTRODUCTION 10
1.1 OBJECTIVES OF THE STUDY 10
1.2 MARKET DEFINITION 10
1.3 OVERVIEW 10
1.4 LIMITATIONS 11
1.5 MARKETS COVERED 12
2 MARKET SEGMENTATION 16
2.1 MARKETS COVERED 16
2.2 GEOGRAPHICAL SCOPE 17
2.3 YEARS CONSIDERED FOR THE STUDY 18
2.4 CURRENCY AND PRICING 18
2.5 DBMR TRIPOD DATA VALIDATION MODEL 19
2.6 MULTIVARIATE MODELING 22
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 23
2.8 DBMR MARKET POSITION GRID 24
2.9 MARKET APPLICATION COVERAGE GRID 25
2.10 DBMR VENDOR SHARE ANALYSIS 26
2.11 SECONDARY SOURCES 27
2.12 ASSUMPTIONS 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 32
4.1 PESTLE ANALYSIS 34
4.1.1 POLITICAL FACTORS: 34
4.1.2 ECONOMIC FACTORS: 35
4.1.3 SOCIAL FACTORS: 35
4.1.4 TECHNOLOGICAL FACTORS: 35
4.1.5 LEGAL FACTORS: 36
4.1.6 ENVIRONMENTAL FACTORS: 37
4.2 PORTERS FIVE FORCES 38
4.3 VENDOR SELECTION CRITERIA 40
5 DYNAMICS OF RAW MATERIAL PREFERENCES 42
5.1 PLASTIC AND POLYMERS: 42
5.1.1 HDPE (HIGH-DENSITY POLYETHYLENE): 42
5.1.2 LDPE (LOW-DENSITY POLYETHYLENE): 42
5.1.3 PET (POLYETHYLENE TEREPHTHALATE): 42
5.1.4 PVC (POLYVINYL CHLORIDE): 42
5.1.5 PP (POLYPROPYLENE): 42
5.1.6 COC (CYCLIC OLEFIN COPOLYMER): 43
5.2 GLASS: 43
5.2.1 TYPE IV-NP (GENERAL PURPOSE SODA LIME GLASS): 43
5.2.2 TYPE I (BOROSILICATE GLASS): 43
5.2.3 TYPE III (REGULAR SODA-LIME GLASS): 43
5.2.4 TREATED SODA LIME GLASS: 44
5.3 METAL: 44
5.3.1 TIN: 44
5.3.2 IRON: 44
5.3.3 ALUMINIUM: 44
5.3.4 LEAD: 44
5.4 PAPER AND BOARD: 45
5.4.1 SOLID BOARD: 45
5.4.2 CHIPBOARD: 45
5.4.3 CARDBOARD: 45
5.4.4 FIBER BOARD: 45
5.5 RUBBER: 46
5.5.1 NATURAL RUBBER IN CONTRACT PHARMACEUTICAL PACKAGING: 46
5.5.2 NEOPRENE RUBBER IN CONTRACT PHARMACEUTICAL PACKAGING: 46
5.5.3 BUTYL RUBBER IN CONTRACT PHARMACEUTICAL PACKAGING: 46
6 PARTNERSHIP DETAILS 47
7 TECHNOLOGICAL ADVANCEMENTS 49
8 MARKET OVERVIEW 51
8.1 DRIVERS 53
8.1.1 STRONG SPENDING TOWARDS PHARMA INDUSTRY 53
8.1.2 IMPACT OF COMPLEX DRUG FORMULATIONS AND SPECIALIZED PACKAGING NEEDS 54
8.1.3 IMPACT OF REGULATORY COMPLIANCE AND QUALITY ASSURANCE DEMANDS 55
8.2 RESTRAINTS 56
8.2.1 AVAILABILITY OF CHOICE OF IN-HOUSE PACKAGING FROM MANUFACTURERS 56
8.2.2 SUSTAINABILITY CONCERNS DUE TO USAGE OF PLASTICS IN PACKAGING MATERIALS 56
8.3 OPPORTUNITIES 57
8.3.1 TECHNOLOGICAL ADVANCEMENTS IN PACKAGING MACHINERY AND MATERIALS 57
8.3.2 RISING NEED FOR BIOPHARMACEUTICAL COLD CHAIN PACKAGING 58
8.4 CHALLENGE 59
8.4.1 DIVERSE CONCERNS RELATED TO OPERATIONAL HURDLES 59
9 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: BY REGION 60
9.1 OVERVIEW 60
9.2 EUROPE 61
9.3 NORTH AMERICA 62
9.4 SOUTH AMERICA 63
9.5 ASIA-PACIFIC 64
9.6 MIDDLE EAST & AFRICA 65
10 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: COMPANY LANDSCAPE 66
10.1 COMPANY SHARE ANALYSIS: GLOBAL 66
10.2 COMPANY SHARE ANALYSIS: EUROPE 67
10.3 COMPANY SHARE ANALYSIS: NORTH AMERICA 68
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 69
11 SWOT ANALYSIS 70
12 COMPANY PROFILE 71
12.1 ABBVIE INC. 71
12.1.1 COMPANY SNAPSHOT 71
12.1.2 REVENUE ANALYSIS 71
12.1.3 COMPANY SHARE ANALYSIS 72
12.1.4 SERVICE PORTFOLIO 72
12.1.5 RECENT DEVELOPMENTS 72
12.2 PCI PHARMA SERVICES 73
12.2.1 COMPANY SNAPSHOT 73
12.2.2 COMPANY SHARE ANALYSIS 73
12.2.3 SERVICE PORTFOLIO 74
12.2.4 RECENT DEVELOPMENTS 74
12.3 NELIPAK CORPORATION 75
12.3.1 COMPANY SNAPSHOT 75
12.3.2 COMPANY SHARE ANALYSIS 75
12.3.3 PRODUCT PORTFOLIO 75
12.3.4 RECENT DEVELOPMENTS 76
12.4 SHARP SERVICES, LLC 77
12.4.1 COMPANY SNAPSHOT 77
12.4.2 COMPANY SHARE ANALYSIS 77
12.4.3 PRODUCT PORTFOLIO 78
12.4.4 RECENT DEVELOPMENTS 79
12.5 APHENA PHARMA SOLUTIONS 80
12.5.1 COMPANY SNAPSHOT 80
12.5.2 COMPANY SHARE ANALYSIS 80
12.5.3 SERVICE PORTFOLIO 81
12.5.4 RECENT DEVELOPMENT 81
12.6 AMERIPAC 82
12.6.1 COMPANY SNAPSHOT 82
12.6.2 PRODUCT PORTFOLIO 82
12.6.3 RECENT DEVELOPMENT 82
12.7 ASSEMBLIES UNLIMITED, INC. 83
12.7.1 COMPANY SNAPSHOT 83
12.7.2 SERVICE PORTFOLIO 83
12.7.3 RECENT DEVELOPMENT 84
12.8 JONES HEALTHCARE GROUP 85
12.8.1 COMPANY SNAPSHOT 85
12.8.2 PRODUCT PORTFOLIO 85
12.8.3 RECENT DEVELOPMENT 86
12.9 REED-LANE 87
12.9.1 SNAPSHOT 87
12.9.2 PRODUCT PORTFOLIO 87
12.9.3 RECENT DEVELOPMENT 88
12.10 ROPACK INC. 89
12.10.1 COMPANY SNAPSHOT 89
12.10.2 PRODUCT PORTFOLIO 89
12.10.3 RECENT DEVELOPMENT 89
12.11 SEPHA 90
12.11.1 COMPANY SNAPSHOT 90
12.11.2 PRODUCT PORTFOLIO 90
12.11.3 RECENT DEVELOPMENTS 91
12.12 SILGANUNICEP 92
12.12.1 COMPANY SNAPSHOT 92
12.12.2 SERVICE PORTFOLIO 92
12.12.3 RECENT DEVELOPMENTS 93
12.13 STERNMAID GMBH & CO. KG 94
12.13.1 COMPANY SNAPSHOT 94
12.13.2 SERVICE PORTFOLIO 94
12.13.3 RECENT DEVELOPMENTS 94
12.14 TJOAPACK 95
12.14.1 COMPANY SNAPSHOT 95
12.14.2 SERVICE PORTFOLIO 95
12.14.3 RECENT DEVELOPMENT 96
12.15 TRIPAK PHARMACEUTICALS 97
12.15.1 COMPANY SNAPSHOT 97
12.15.2 SERVICE PORTFOLIO 97
12.15.3 RECENT DEVELOPMENTS 97
12.16 WASDELL PACKAGING GROUP 98
12.16.1 COMPANY SNAPSHOT 98
12.16.2 PRODUCT PORTFOLIO 98
12.16.3 RECENT DEVELOPMENT 98
13 QUESTIONNAIRE 99
14 RELATED REPORTS 102

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.